vs
LIGHTPATH TECHNOLOGIES INC（LPTH）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是LIGHTPATH TECHNOLOGIES INC的1.7倍（$28.1M vs $16.4M），LIGHTPATH TECHNOLOGIES INC净利率更高（-57.5% vs -147.1%，领先89.6%），LIGHTPATH TECHNOLOGIES INC同比增速更快（120.2% vs -67.6%）
LightPath Technologies Inc是一家精密光学组件及组件生产商，主营非球面透镜、红外光学器件、光纤产品等，服务工业自动化、航空航天、国防、医疗成像、电信等领域的全球客户，提供标准及定制化光学解决方案。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
LPTH vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.7倍
$16.4M
营收增速更快
LPTH
高出187.8%
-67.6%
净利率更高
LPTH
高出89.6%
-147.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.4M | $28.1M |
| 净利润 | $-9.4M | $-41.3M |
| 毛利率 | 36.8% | — |
| 营业利润率 | -52.6% | -147.6% |
| 净利率 | -57.5% | -147.1% |
| 营收同比 | 120.2% | -67.6% |
| 净利润同比 | -260.1% | -182.8% |
| 每股收益（稀释后） | $-0.20 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LPTHSPRY
| Q4 25 | $16.4M | $28.1M | ||
| Q3 25 | $15.1M | $32.5M | ||
| Q2 25 | $12.2M | $15.7M | ||
| Q1 25 | $9.2M | $8.0M | ||
| Q4 24 | $7.4M | $86.6M | ||
| Q3 24 | $8.4M | $2.1M | ||
| Q2 24 | $8.6M | $500.0K | ||
| Q1 24 | $7.7M | $0 |
净利润LPTHSPRY
| Q4 25 | $-9.4M | $-41.3M | ||
| Q3 25 | $-2.9M | $-51.2M | ||
| Q2 25 | $-7.1M | $-44.9M | ||
| Q1 25 | $-3.6M | $-33.9M | ||
| Q4 24 | $-2.6M | $49.9M | ||
| Q3 24 | $-1.6M | $-19.1M | ||
| Q2 24 | $-2.4M | $-12.5M | ||
| Q1 24 | $-2.6M | $-10.3M |
毛利率LPTHSPRY
| Q4 25 | 36.8% | — | ||
| Q3 25 | 29.8% | — | ||
| Q2 25 | 22.0% | — | ||
| Q1 25 | 29.1% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 29.2% | — | ||
| Q1 24 | 20.9% | — |
营业利润率LPTHSPRY
| Q4 25 | -52.6% | -147.6% | ||
| Q3 25 | -16.6% | -163.7% | ||
| Q2 25 | -38.0% | -302.9% | ||
| Q1 25 | -36.3% | -466.3% | ||
| Q4 24 | -33.5% | 54.5% | ||
| Q3 24 | -16.4% | -1051.6% | ||
| Q2 24 | -25.6% | -3068.0% | ||
| Q1 24 | -33.6% | — |
净利率LPTHSPRY
| Q4 25 | -57.5% | -147.1% | ||
| Q3 25 | -19.2% | -157.4% | ||
| Q2 25 | -57.8% | -285.6% | ||
| Q1 25 | -39.1% | -425.7% | ||
| Q4 24 | -35.2% | 57.7% | ||
| Q3 24 | -19.3% | -925.0% | ||
| Q2 24 | -27.3% | -2503.2% | ||
| Q1 24 | -33.7% | — |
每股收益（稀释后）LPTHSPRY
| Q4 25 | $-0.20 | $-0.41 | ||
| Q3 25 | $-0.07 | $-0.52 | ||
| Q2 25 | $0.19 | $-0.46 | ||
| Q1 25 | $-0.44 | $-0.35 | ||
| Q4 24 | $-0.07 | $0.52 | ||
| Q3 24 | $-0.04 | $-0.20 | ||
| Q2 24 | $-0.15 | $-0.13 | ||
| Q1 24 | $-0.07 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.6M | $245.0M |
| 总债务越低越好 | — | $96.4M |
| 股东权益账面价值 | $77.9M | $114.3M |
| 总资产 | $148.6M | $327.7M |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资LPTHSPRY
| Q4 25 | $73.6M | $245.0M | ||
| Q3 25 | — | $288.2M | ||
| Q2 25 | $4.9M | $240.1M | ||
| Q1 25 | — | $275.7M | ||
| Q4 24 | — | $314.0M | ||
| Q3 24 | — | $204.6M | ||
| Q2 24 | — | $218.7M | ||
| Q1 24 | — | $223.6M |
总债务LPTHSPRY
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | $535.0K | — | ||
| Q1 24 | $599.4K | — |
股东权益LPTHSPRY
| Q4 25 | $77.9M | $114.3M | ||
| Q3 25 | $21.4M | $147.7M | ||
| Q2 25 | $15.6M | $192.3M | ||
| Q1 25 | $15.7M | $229.0M | ||
| Q4 24 | $26.7M | $256.8M | ||
| Q3 24 | $29.4M | $201.0M | ||
| Q2 24 | $30.2M | $215.2M | ||
| Q1 24 | $31.7M | $223.9M |
总资产LPTHSPRY
| Q4 25 | $148.6M | $327.7M | ||
| Q3 25 | $87.3M | $372.8M | ||
| Q2 25 | $81.5M | $313.5M | ||
| Q1 25 | $81.4M | $327.3M | ||
| Q4 24 | $45.8M | $351.2M | ||
| Q3 24 | $48.4M | $217.6M | ||
| Q2 24 | $48.1M | $222.0M | ||
| Q1 24 | $49.7M | $227.6M |
负债/权益比LPTHSPRY
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.8M | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | — |
| 自由现金流率自由现金流/营收 | 12.0% | — |
| 资本支出强度资本支出/营收 | 5.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.3M | — |
8季度趋势，按日历期对齐
经营现金流LPTHSPRY
| Q4 25 | $2.8M | $-43.5M | ||
| Q3 25 | $-1.1M | $-47.0M | ||
| Q2 25 | $-2.6M | $-39.6M | ||
| Q1 25 | $-3.2M | $-40.7M | ||
| Q4 24 | $-737.4K | $42.0M | ||
| Q3 24 | $-1.7M | $-14.5M | ||
| Q2 24 | $64.7K | $-7.3M | ||
| Q1 24 | $-394.2K | $-6.7M |
自由现金流LPTHSPRY
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-1.2M | $-47.2M | ||
| Q2 25 | $-3.3M | $-39.6M | ||
| Q1 25 | $-3.7M | $-40.8M | ||
| Q4 24 | $-817.8K | $41.7M | ||
| Q3 24 | $-1.8M | $-14.6M | ||
| Q2 24 | $-225.5K | $-7.3M | ||
| Q1 24 | $-802.5K | $-6.8M |
自由现金流率LPTHSPRY
| Q4 25 | 12.0% | — | ||
| Q3 25 | -8.1% | -145.4% | ||
| Q2 25 | -27.3% | -252.2% | ||
| Q1 25 | -40.0% | -512.1% | ||
| Q4 24 | -11.0% | 48.2% | ||
| Q3 24 | -21.2% | -706.3% | ||
| Q2 24 | -2.6% | -1463.4% | ||
| Q1 24 | -10.4% | — |
资本支出强度LPTHSPRY
| Q4 25 | 5.3% | 0.0% | ||
| Q3 25 | 0.5% | 0.6% | ||
| Q2 25 | 5.6% | 0.3% | ||
| Q1 25 | 4.6% | 1.1% | ||
| Q4 24 | 1.1% | 0.3% | ||
| Q3 24 | 0.9% | 6.8% | ||
| Q2 24 | 3.4% | 7.6% | ||
| Q1 24 | 5.3% | — |
现金转化率LPTHSPRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPTH
| Other | $7.9M | 48% |
| Infrared Components | $5.0M | 31% |
| Visible Components | $3.4M | 21% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
